GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » EV-to-Revenue

Polaris AI Pharma (XKRX:041910) EV-to-Revenue : 1.22 (As of May. 30, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Polaris AI Pharma's enterprise value is ₩74,349 Mil. Polaris AI Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩61,167 Mil. Therefore, Polaris AI Pharma's EV-to-Revenue for today is 1.22.

The historical rank and industry rank for Polaris AI Pharma's EV-to-Revenue or its related term are showing as below:

XKRX:041910' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.69   Med: 1.91   Max: 23.63
Current: 1.22

During the past 13 years, the highest EV-to-Revenue of Polaris AI Pharma was 23.63. The lowest was 0.69. And the median was 1.91.

XKRX:041910's EV-to-Revenue is ranked better than
72.8% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs XKRX:041910: 1.22

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Polaris AI Pharma's stock price is ₩8800.00. Polaris AI Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩5,237.09. Therefore, Polaris AI Pharma's PS Ratio for today is 1.68.


Polaris AI Pharma EV-to-Revenue Historical Data

The historical data trend for Polaris AI Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma EV-to-Revenue Chart

Polaris AI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.77 1.52 1.02 0.86 0.85

Polaris AI Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.02 0.79 0.85 1.55

Competitive Comparison of Polaris AI Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Polaris AI Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris AI Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Polaris AI Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Polaris AI Pharma's EV-to-Revenue falls into.



Polaris AI Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Polaris AI Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=74349.459/61166.987
=1.22

Polaris AI Pharma's current Enterprise Value is ₩74,349 Mil.
Polaris AI Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩61,167 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris AI Pharma  (XKRX:041910) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Polaris AI Pharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8800.00/5237.091
=1.68

Polaris AI Pharma's share price for today is ₩8800.00.
Polaris AI Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,237.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris AI Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris AI Pharma (XKRX:041910) Business Description

Traded in Other Exchanges
N/A
Address
1407-9, Hagil-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-938
Estechpharma Co Ltd is engaged in the manufacture and supply of pharmaceutical ingredients and fine chemicals in South Korea.

Polaris AI Pharma (XKRX:041910) Headlines

No Headlines